A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
Organizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.
by Cheryl Platzman Weinstock
Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
The End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
Drugs approved through this pathway may have limited evidence.
by Lindsey Konkel
Let your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
A new vaccine is safe for cancer patients but hard to find.
by Nancy Averett
In the past few decades, most of the progress that has been made against cervical cancer has been in the areas of prevention and early detection.
The U.S. Food and Drug Administration rounded out 2018 with three oncology approvals.
What are the side effects of immune checkpoint inhibitors and how do they arise?
Bob Riter: The Bridge Builder
donate to the AACR